Model Number 12A19 |
Device Problem
Gradient Increase (1270)
|
Patient Problem
Valvular Stenosis (2697)
|
Event Type
Injury
|
Manufacturer Narrative
|
According to the physician, the patient¿s medication (prednisolone) could contribute to this early valve dysfunction, because this medicine is a strong anti-inflammatory agent and thrombosis is known as one of adverse effects with a long-term administration.However, at this point there is no indication of valve failure specifically due to thrombosis, so the relationship of the event to the patient's medication remains unknown.The manufacturer was notified that further information, such as the patient's medical history, is not available for this case.Device not explanted.
|
|
Event Description
|
On (b)(6) 2014, a mitroflow valve was implanted due to stenosis and increased pressure gradient.The patient also exhibited aortitis.A bentall operation was performed, and the mitroflow valve was implanted.In (b)(6) 2017, mitroflow valve stenosis was reported to have rapidly progressed within the previous 6 months, and increased pressure gradient was observed.A valve-in-valve procedure was performed.No further information was available at the time of reporting this event.
|
|
Event Description
|
Manufacturer received additional information on (b)(6) 2018 that poor leaflet movement was observed in one leaflet on echo observation.The patient had been taking steroid drug, but it is unknown if this drug could contribute to aortic stenosis.This patient fainted twice, but the detail cause is unknown.
|
|
Search Alerts/Recalls
|
|